Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$531M |
| 2 |
Kinder Morgan
KMI
|
+$496M |
| 3 |
IBM
IBM
|
+$253M |
| 4 |
CA
CA, Inc.
CA
|
+$213M |
| 5 |
Estee Lauder
EL
|
+$209M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$385M |
| 2 |
Microsoft
MSFT
|
+$381M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$351M |
| 4 |
Apple
AAPL
|
+$333M |
| 5 |
Johnson & Johnson
JNJ
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.32% |
| 2 | Healthcare | 14.17% |
| 3 | Financials | 13.97% |
| 4 | Industrials | 10.35% |
| 5 | Consumer Discretionary | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Lattice Semiconductor
LSCC
$18.5B
| $44.6M | 0.01% |
6,473,757
+125,223
| +2% | +$822K |
|
952
Tyler Technologies
TYL
$13.5B
| $44.5M | 0.01% |
406,737
+43,570
| +12% | +$4.6M |
|
|
SFG
953
DELISTED
STANCORP FINL GRP
SFG
| $44.4M | 0.01% |
634,885
-30,157
| -5% | -$2.01M |
|
|
TYPE
954
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| $44.3M | 0.01% |
1,535,163
-16,105
| -1% | -$451K |
|
955
TherapeuticsMD
TXMD
$24M
| $44.2M | 0.01% |
198,780
-7,101
| -3% | -$1.46M |
|
|
UCB
956
United Community Banks
UCB
$4.43B
| $44.2M | 0.01% |
2,333,299
-148,104
| -6% | -$2.61M |
|
|
RAD
957
DELISTED
Rite Aid Corporation
RAD
| $44.2M | 0.01% |
293,580
-30,331
| -9% | -$3.37M |
|
958
Ionis Pharmaceuticals
IONS
$9.51B
| $44.1M | 0.01% |
714,450
-12,225
| -2% | -$603K |
|
959
STAG Industrial
STAG
$7.09B
| $44M | 0.01% |
1,796,925
+1,428,515
| +388% | +$33.7M |
|
|
CBL
960
DELISTED
CBL& Associates Properties, Inc.
CBL
| $44M | 0.01% |
2,265,596
+1,217,022
| +116% | +$22.9M |
|
|
CVSA
961
Covista Inc
CVSA
$4.49B
| $44M | 0.01% |
926,036
-91,975
| -9% | -$4.32M |
|
962
Acadia Healthcare
ACHC
$2.87B
| $43.9M | 0.01% |
717,096
-97,057
| -12% | -$5.65M |
|
963
PRA Group
PRAA
$776M
| $43.9M | 0.01% |
757,643
-403,773
| -35% | -$23.8M |
|
964
AptarGroup
ATR
$8.4B
| $43.8M | 0.01% |
655,150
-15,060
| -2% | -$955K |
|
|
FMBI
965
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $43.8M | 0.01% |
2,558,326
-111,034
| -4% | -$1.84M |
|
966
Vanguard FTSE Developed Markets ETF
VEA
$239B
| $43.6M | 0.01% |
1,151,988
-79,135
| -6% | -$3.06M |
|
967
Herc Holdings
HRI
$5.8B
| $43.6M | 0.01% |
582,559
-8,163
| -1% | -$552K |
|
|
VVC
968
DELISTED
Vectren Corporation
VVC
| $43.5M | 0.01% |
941,889
-27,358
| -3% | -$1.2M |
|
969
Brinker International
EAT
$10.2B
| $43.5M | 0.01% |
740,769
-40,839
| -5% | -$2.23M |
|
|
CMCSK
970
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
| $43.2M | 0.01% |
751,179
+10,821
| +1% | +$623K |
|
971
Flotek Industries
FTK
$1.3B
| $43.1M | 0.01% |
383,480
+260,534
| +212% | +$32.2M |
|
|
TUP
972
DELISTED
Tupperware Brands Corporation
TUP
| $43.1M | 0.01% |
684,007
+79,361
| +13% | +$5.19M |
|
|
SHPG
973
DELISTED
Shire pic
SHPG
| $43.1M | 0.01% |
202,751
+53,672
| +36% | +$11.4M |
|
974
Thomson Reuters
TRI
$44.9B
| $43M | 0.01% |
918,387
-40,697
| -4% | -$1.8M |
|
|
RGC
975
DELISTED
Regal Entertainment Group
RGC
| $42.9M | 0.01% |
2,010,064
-92,414
| -4% | -$1.95M |
|
Similar funds
Bank of New York Mellon's Q4 2014 Portfolio in Review
As of Q4 2014, Bank of New York Mellon held 4,419 positions worth $383B, up 3.9% from $368B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Bank of New York Mellon's Q4 2014 filing shows 190 new, 1,733 increased, 2,081 reduced and 173 closed positions. Its largest new stake was UBS Group: 11,155,329 shares worth $190M. The largest sale was Intel, an estimated $385M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q4 2014 buy was UBS Group: 11,155,329 shares worth $190M.
- Bank of New York Mellon added most to Gilead Sciences in Q4 2014, an estimated $531M increase.
- Bank of New York Mellon's biggest Q4 2014 reduction was Intel, cutting an estimated $385M.
- Bank of New York Mellon fully exited CONCUR TECHNOLOGIES INC in Q4 2014, selling an estimated $113M.
- Bank of New York Mellon's ten largest holdings make up 13% of its $383B portfolio in Q4 2014.
- Bank of New York Mellon opened 190 new positions and closed 173 in Q4 2014.
- Bank of New York Mellon's portfolio value rose 3.9% quarter-over-quarter to $383B.
Based on Bank of New York Mellon's 13F filing for Q4 2014, filed 17 Feb 2015.